Agreed. That is why I posted that link for all our

New Post Public Reply Private Reply Replies (0) Message Board
Babaji Boatbuilder #46656
909
Agreed. That is why I posted that link for all our enthusiastic posters to hopefully read - an unbiased explanation of the process of getting a new med qualified.

Having said that, sometimes I wish they would tone down their projecting “precise” schedules which are dependent on others and not in their control. Gets us excited only to learn of the pitfalls of these forecasts.

Our communities expectations are also often misinformed and they take on a life of their own. NP was very clear on the purpose of his last CC to present “Updates” on the current trials and next steps. Which he did and, if one was listening carefully to all the presenters (note he gave all the doctors a chance to present) there was seriously good news disseminated but carefully done!

I had to go look up the NEWS 2 protocol. Never heard of it but he was passionate about trying to tell us that this protocol will pull us over the finish line in the mm (CD10) trials. The NEWS 2 protocol is designed to measure specific metrics in a patients disease progress (see link below). The NEWS 2 protocol is used to provide standardized information to predict the potential of a patient progressing to severe status (in this trial). NP said that the data showed that the drugged arm of the mm trial outperformed the placebo arm in EVERY measurement milestone they had, day 3, day 7 and day 14! Though he could not present specific tables of data, he said THIS IS GREAT NEWS! He repeated this to a questioner as well. I choose to believe him and comfortable that we will outshine every other medicine tested similarly.

https://www.rcplondon.ac.uk/news/news2-and-de...n-covid-19

Next CD10 update will be “Too Line Results” and I hope our community understand what this means.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Michigan Roof Inspections: Seasonal Insights That Count

Updated Category News Views 2

Weather's Wrath and the Michigan Roof Here's the deal: Michigan doesn't mess around when it comes to weather. We're talking harsh winters with piles of snow, followed by muggy summers that toss storms like they're confetti. Keeping that roof in top shape isn't just some luxury; it’s a downright necessity. Gut-punch reality? Many ignore it until it's too late. That's...

Continue Reading
CIMAMotor 2026: A Massive Gathering in Motorcycle Mecca

Updated Category News Views 2

Unprecedented Scale at CIMAMotor 2026 Come September, the 24th China International Motorcycle Trade Exhibition, also known as CIMAMotor 2026, is set to roar through the corridors of the Chongqing International Expo Center. With more than 1,000 exhibitors and over 3,000 vehicles on display, it’s clear this isn’t just another trade show—this is a full-blown spectacle...

Continue Reading
Global Movement Urges Dr. Hak Ja Han's Release

Updated Category News Views 4

Under the shadows of Manhattan's skyline, something more than a regular service took shape. The New Yorker Hotel hosted an impassioned gathering of the Family Federation for World Peace and Unification. These folks weren't just saying their prayers; they were making a call—loud and resonant—for the release of Dr. Hak Ja Han. The Power of Collective Voices Gathering in...

Continue Reading
Sungrow's MGTL Series: A Game-Changer in Solar Tech

Updated Category News Views 2

Smarter Energy Systems Are Here Gone are the days when solar inverters were just clunky bits of tech you threw on a roof. Sungrow's latest MGTL Series, revealed in Da Nang, marks a revolutionary step for Southeast Asia, Africa, Latin America, and beyond. They're not just talking the talk—they're bringing real innovation to the table. Why the MGTL Series Stands Out Look,...

Continue Reading
Frost & Sullivan's Bold Subscription Move Signals Growth

Updated Category News Views 0

New Leadership Steers Strategic Growth Just when you thought the subscription game couldn't get more interesting, in steps Janesh Janardhanan. Frost & Sullivan, the big brain of analytics and growth advice, has handed him the reins of their fancy subscriptions portfolio. Janardhanan's job? To pump some muscle into their global growth and ensure their analytics and...

Continue Reading
Sky Labs' CART Monitor Advances BP Monitoring Tech

Updated Category News Views 2

Cuffless BP Monitoring: Changing the Game for AF and HF Ever thought a finger ring could revolutionize blood pressure monitoring? Well, welcome to the future—Sky Labs' ring-type CART monitor has just rocked the scene at the ESC Congress 2026 in Munich. This isn't sci-fi, folks; it's where health tech meets reality, and it's shaking the very foundations of how we manage...

Continue Reading
Nurminen Logistics Doubles Sweden–Italy Rail Capacity

Updated Category News Views 3

Nurminen Logistics Betting Big on Rail Expansion Feeling the pulse of the logistics world is much like trying to catch lightning in a bottle, but Nurminen Logistics seems to have found its rhythm. They're ramping up their services between Sweden and Italy, leveraging rail to push the envelope. Come October, they're doubling down from one to two weekly departures, giving...

Continue Reading
Snack Bars Market to Hit $32.66B by 2031: Growth and Challenges

Updated Category News Views 1

Snack Bars Navigate a Transforming Market There's a headwind in the snack bars market as it looks to lift off from $21.94 billion and land at $32.66 billion by 2031. That's a solid climb at an 8.28% CAGR. What's fueling this leap? A desire for convenient, portable nutrition that's squeezing into every nook of modern life—from the gym to the car, to your kid's lunchbox....

Continue Reading
CalExitNow Fights Federal Interference in CA Elections

Updated Category News Views 2

California's Election Integrity: A Ticking Time Bomb Strap in for a bumpy ride, folks—California might soon find its electoral process caught in a Washington whirlwind. CalExitNow, the group advocating for California's independence, is sounding alarms about looming federal interventions that could shake the state's democratic foundations. The Federal Storm Rolling In...

Continue Reading
Navimow Powers TOP 14 with Tech: A Winning Play

Updated Category News Views 4

A Technological Leap for French Rugby Innovation and precision in partnerships—those words don't usually pop up together when chatting about a rugby league. But here we are, discussing the TOP 14, the elite French rugby championship, pairing up with Segway Navimow. This brand, under the umbrella of Ninebot Limited (689009.SH), is stepping into the world of sports for...

Continue Reading

Top 5 Most Recently Viewed Articles

Tevogen Bio Advocates for Long COVID Solutions on Capitol Hill

Updated Category News Views 70

Tevogen Bio Champions Long COVID Patient Advocacy Tevogen Bio, a clinical-stage biotech company specializing in immunotherapy, is drawing attention for its proactive stance on important healthcare challenges. Recently, the company has turned its focus to advocating for patients with Long COVID. This initiative gained prominence when Tevogen's leadership met with members...

Continue Reading
Rybelsus® Shows Promising Cardiovascular Benefits in SOUL Trial

Updated Category News Views 515

Rybelsus® Shows Significant Reduction in Cardiovascular Events Recent findings from the SOUL cardiovascular outcomes trial have highlighted the effectiveness of Rybelsus® (oral semaglutide) in significantly reducing the risk of major adverse cardiovascular events (MACE) among adults suffering from type 2 diabetes and associated conditions. Clinical data from the trial...

Continue Reading
Quipt Home Medical Reports Promising Q1 Fiscal 2025 Results

Updated Category News Views 312

Quipt Home Medical's Strong Start to Fiscal Year 2025 Quipt Home Medical Corp. (NASDAQ: QIPT; TSX: QIPT), a prominent provider of home medical equipment with a focus on respiratory care, shared its financial results for the first quarter of fiscal year 2025, covering the three-month period ending December 31, 2024. Diligently reported in U.S. Dollars, these results...

Continue Reading
Argent BioPharma Secures $4.5 Million in Capital Raise

Updated Category News Views 147

Argent BioPharma's Successful Capital Raise and Future Prospects Argent BioPharma Limited (ASX: RGT) is a clinical-stage biopharmaceutical company that focuses on developing innovative treatments for central nervous system (CNS) and immune-related disorders through advanced nano-medicine technology and neuro-immune modulation. Recently, Argent BioPharma announced a...

Continue Reading
Bernie Sanders Highlights High Costs of Ozempic and Patient Impact

Updated Category News Views 56

Bernie Sanders Criticizes High Costs of Ozempic Senator Bernie Sanders has recently expressed his deep frustration over the soaring prices of Ozempic, a medication made by Novo Nordisk A/S (NYSE: NVO). While it’s primarily prescribed for managing diabetes, Ozempic has also become popular as a weight loss solution. Inconsistent Medication Prices In a fervent post on...

Continue Reading